Clincosm LogoSign in Get a demo

Renal Cell Carcinoma (RCC)

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma, Hepatocellular Carcinoma (HCC), Renal Cell Carcinoma (RCC) Trial (INCB 99280 with Ipilimumab)

Not yet recruiting
  • Melanoma
  • +5 more
  • INCB 99280 with Ipilimumab
  • (no location specified)
Jun 9, 2023

Advanced Cancer, Advanced Malignancies, Bladder Cancer Trial (AB598, Zimberelimab, Carboplatin)

Not yet recruiting
  • Advanced Cancer
  • +11 more
  • (no location specified)
May 26, 2023

Renal Cell Carcinoma (RCC), Urothelial Carcinoma, Primary Peritoneal Cancer Trial in Canada, United States (DSP-7888 Dosing

Completed
  • Renal Cell Carcinoma (RCC)
  • +5 more
  • DSP-7888 Dosing Emulsion
  • +2 more
  • Tucson, Arizona
  • +18 more
Dec 6, 2022

Renal Cell Carcinoma (RCC) Trial in Birmingham (Trans-arterial embolization (TAE))

Not yet recruiting
  • Renal Cell Carcinoma (RCC)
  • Trans-arterial embolization (TAE)
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 5, 2022

NSCLC (NSCLC), Triple Negative Breast Cancer (TNBC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in Worldwide (NZV930, PDR001,

Terminated
  • Non-small Cell Lung Cancer (NSCLC)
  • +6 more
  • NZV930
  • +2 more
  • Tampa, Florida
  • +9 more
Nov 2, 2022

Renal Cell Carcinoma (RCC) Trial in Heidelberg (Chimeric mAb cG250, Sunitinib malate)

Terminated
Has Results
  • Renal Cell Carcinoma (RCC)
  • Chimeric monoclonal antibody cG250
  • Sunitinib malate
  • Heidelberg, Victoria, Australia
    Austin Health (Ludwig Institute Oncology Unit)
Oct 3, 2022

Cancer of Kidney, Kidney Cancer, Renal Cancer Trial in New York (124-Iodine-cG250 (124I-cG250))

Completed
Has Results
  • Cancer of Kidney
  • +6 more
  • 124-Iodine-cG250 (124I-cG250)
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Melanoma, Non-small Cell Lung Carcinoma (NSCLC), Renal Cell Carcinoma (RCC) Trial in Gainesville, Jacksonville (LITT +

Recruiting
  • Melanoma
  • +14 more
  • LITT + Pembrolizumab
  • Gainesville, Florida
  • +1 more
Aug 22, 2022

Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC) Trial in Worldwide (INCB001158, Pembrolizumab)

Active, not recruiting
Has Results
  • Metastatic Cancer
  • +9 more
  • Mobile, Alabama
  • +19 more
Aug 1, 2022

Renal Cell Carcinoma (RCC) Trial in Worldwide (Pembrolizumab, Epacadostat, Sunitinib)

Active, not recruiting
Has Results
  • Renal Cell Carcinoma (RCC)
  • Scottsdale, Arizona
  • +139 more
Jun 3, 2022

Multimodal Machine Learning Characterization of Solid Tumors

Recruiting
  • Adenocarcinoma of Prostate
  • +5 more
  • Boston, Massachusetts
  • +1 more
Apr 4, 2022

Colorectal Cancer (CRC), Endometrial Cancer, Melanoma Trial in United States (Pembrolizumab, itacitinib, INCB050465)

Completed
  • Colorectal Cancer (CRC)
  • +10 more
  • San Francisco, California
  • +16 more
Mar 30, 2022

Renal Cell Carcinoma (RCC) Trial in Milan (18F-FAZA PET IMAGING TECHNIQUE IN DETECTING LYMPH NODE METASTASES IN RENAL CELL

Completed
  • Renal Cell Carcinoma (RCC)
  • 18F-FAZA PET IMAGING TECHNIQUE IN DETECTING LYMPH NODE METASTASES IN RENAL CELL CARCINOMA PATIENTS
  • Milan, Italy
    IRCCS San Raffaele
Dec 18, 2020

Renal Cell Carcinoma (RCC), Cancer Trial in Worldwide (pazopanib, )

Completed
Has Results
  • Renal Cell Carcinoma (RCC)
  • Cancer
  • Jonesboro, Arkansas
  • +311 more
Oct 29, 2020

Cervical Cancer, Microsatellite Instability (MSI)-High Endometrial Cancer, Gastric Cancer (Including Stomach and

Completed
  • Cervical Cancer
  • +16 more
  • INCAGN02385
  • Los Angeles, California
  • +3 more
Oct 28, 2020

Renal Cell Carcinoma (RCC), Clear-cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Trial in United States (CDX-014)

Terminated
  • Renal Cell Carcinoma (RCC)
  • +5 more
  • Scottsdale, Arizona
  • +4 more
Jun 2, 2020

Melanoma, Renal Cell Carcinoma (RCC), NSCLC (NSCLC) Trial in Baltimore (PET/CT imaging with [18F]

Completed
  • Melanoma
  • +2 more
  • PET/CT imaging with [18F] 2-deoxy-2-(18F)fluoro-D-glucose (FDG)
  • Baltimore, Maryland
    Johns Hopkins University
Feb 6, 2019

Renal Cell Carcinoma (RCC), Alveolar Soft Part Sarcoma (ASPS), Clear Cell Sarcoma (CCS) Trial in Canada, United Kingdom, United

Completed
  • Renal Cell Carcinoma (RCC)
  • +2 more
  • ARQ 197
  • San Francisco, California
  • +8 more
Feb 6, 2013